Group One Trading’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.8K Sell
18,700
-5,400
-22% -$21.8K ﹤0.01% 5016
2026
Q2
$102K Buy
24,100
+20,100
+503% +$92.1K ﹤0.01% 4831
2026
Q1
$18.6K Buy
4,000
+3,500
+700% +$20K ﹤0.01% 6014
2025
Q4
$3.54K Sell
500
-100
-17% -$737 ﹤0.01% 7332
2025
Q3
$4.64K Hold
600
– – ﹤0.01% 7580
2025
Q2
$4.17K Sell
600
-300
-33% -$2.39K ﹤0.01% 7156
2025
Q1
$7.64K Buy
900
+600
+200% +$7.07K ﹤0.01% 6423
2024
Q4
$4.2K Hold
300
– – ﹤0.01% 6484
2024
Q3
$6.79K Buy
+300
New +$6.92K ﹤0.01% 5766
2024
Q2
– Sell
-2,000
Closed -$49.8K – 6719
2024
Q1
$49.8K Sell
2,000
-16,100
-89% -$342K ﹤0.01% 4728
2023
Q4
$327K Sell
18,100
-32,100
-64% -$531K ﹤0.01% 3441
2023
Q3
$1.01M Sell
50,200
-37,500
-43% -$858K ﹤0.01% 2266
2023
Q2
$2.24M Buy
87,700
+49,100
+127% +$1.14M 0.01% 1604
2023
Q1
$821K Hold
38,600
– – ﹤0.01% 2304
2022
Q4
$1.14M Buy
+38,600
New +$1.04M ﹤0.01% 2295

Other funds holding BCYC

Group One Trading's BCYC Position: Q3 2026 in Review

Group One Trading increased its Bicycle Therapeutics (BCYC) stake by 72% in Q3 2026, buying an estimated $5.66K and bringing the position to 3,338 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6184.

Group One Trading first reported a position in BCYC in Q4 2022 and has held it in 11 quarters since. The position peaked at $2.14M in Q2 2023. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.

  • Group One Trading held 3,338 shares of Bicycle Therapeutics worth $12.3K as of Q3 2026.
  • Group One Trading bought 1,400 Bicycle Therapeutics shares in Q3 2026, an estimated $5.66K.
  • Bicycle Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6184 holding.
  • Group One Trading first reported a position in Bicycle Therapeutics in Q4 2022 and has held it in 11 quarters since.
  • Group One Trading's Bicycle Therapeutics position peaked at $2.14M in Q2 2023.
  • 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.